Opus Genetics (IRD) Short-term Investments (2010 - 2025)
Opus Genetics (IRD) posted quarterly Short-term Investments of $1000.0 for Q1 2025, down 80.0% year-over-year from $5000.0 in Q1 2024, and down 50.0% quarter-over-quarter from $2000.0 in Q4 2024.
Opus Genetics (IRD) Short-term Investments (2010 - 2025) Analysis & Trends
Opus Genetics (IRD) has reported Short-term Investments for 15 consecutive years, with $1000.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Short-term Investments fell 80.0% year-over-year to $1000.0; the TTM figure through Mar 2025 stood at $1000.0 (down 80.0% YoY), while the FY2024 annual figure was $2000.0, down 86.67% from the prior year.
- Short-term Investments slipped to $1000.0 in Q1 2025 per IRD's latest filing, from $2000.0 in the prior quarter.
- Across five years, Short-term Investments topped out at $383000.0 in Q3 2021 and bottomed at $1000.0 in Q1 2025.
- Historically, Short-term Investments has averaged $73266.7 across 5 years, with a median of $22000.0 in 2023.
- On a YoY basis, Short-term Investments climbed as much as 69.39% in 2023 and fell as far as 89.11% in 2023.
- Opus Genetics' Short-term Investments stood at $219000.0 in 2021, then sank by 77.63% to $49000.0 in 2022, then plunged by 69.39% to $15000.0 in 2023, then slumped by 86.67% to $2000.0 in 2024, then slumped by 50.0% to $1000.0 in 2025.
- Business Quant data shows IRD's Short-term Investments at $1000.0 in Q1 2025, $2000.0 in Q4 2024, and $3000.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Opus Genetics | 298.36 Mn | 209.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 49,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 126,000.00 |
| Mar 31, 2022 | 135,000.00 |
| Dec 31, 2021 | 219,000.00 |
| Sep 30, 2021 | 383,000.00 |
| Dec 31, 2019 | 3.00 Mn |
| Sep 30, 2019 | 5.98 Mn |
| Jun 30, 2019 | 8.95 Mn |
| Mar 31, 2019 | 11.89 Mn |
| Dec 31, 2018 | 5.98 Mn |